Formulation

Aug 01, 2015
BioPharm International
The authors explore the use of statistical experimental design and multivariate analysis to develop a drug substance formulation matrix.
Jul 28, 2015
Will AbbVie stave off biosimilar competitors by following Teva’s model for Copaxone?
Jul 07, 2015
By BioPharm International Editors
Catalent’s licensing of Excelimmune’s antibody combination therapy platform can enable more consistent, cost effective production of antibody combinations.
Jul 01, 2015
By BioPharm International Editors
The new facility expands the company’s commercial manufacturing capability at its Bend, Ore. site.
Jul 01, 2015
BioPharm International
When using media supplements in biologics, it is important to have a key understanding of both the supplement and the base medium to ensure high titer and stability.
Jun 15, 2015
BioPharm International
By BioPharm International Editors
Contract service providers share insights on biopharma market developments and the implications of biosimilar drug approvals.
May 28, 2015
By BioPharm International Editors
Experts attending the European Psychiatry Association Congress in Vienna say that Adasuve has made an impact in the treatment of agitation in patients suffering from schizophrenia or bipolar I disorder.
May 19, 2015
The method patent covers the infusion of bendamustine hydrochloride for the treatment of certain blood cancers.
Apr 01, 2015
BioPharm International
Second-generation needle-free injection systems will make parenteral drug administration more convenient, efficient, and safe.
Apr 01, 2015
BioPharm International
Ethylene vinyl acetate (EVA) drug-release technologies are explored.
native1_300x100
lorem ipsum